Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
CU Ophthalmology Researcher Awarded Funding to Further Study Uveitis and Ocular Inflammation – CU Anschutz newsroom
CU Ophthalmology Researcher Awarded Funding to Further Study Uveitis and Ocular Inflammation CU Anschutz newsroom Source: Author: | Date: 2024-09-09 07:00:00 Source: Author: | Date: 2024-09-09 07:00:00
Ophthalmology Innovator Joins NYU Langone Health as Chief of Oculoplastics – NYU Langone Health
Ophthalmology Innovator Joins NYU Langone Health as Chief of Oculoplastics NYU Langone Health Source: Author: | Date: 2024-09-06 07:00:00 Source: Author: | Date: 2024-09-06 07:00:00
Michaël J. A. Girard, PhD – Emory School of Medicine
Michaël J. A. Girard, PhD Emory School of Medicine Source: Author: | Date: 2024-08-23 05:43:00 Source: Author: | Date: 2024-08-23 05:43:00
Photobiomodulation use in ophthalmology – an overview of translational research from bench to bedside – Frontiers
Photobiomodulation use in ophthalmology – an overview of translational research from bench to bedside Frontiers Source: Author: | Date: 2024-08-15 06:23:00 Source: Author: | Date: 2024-08-15 06:23:00
Ocular Therapeutix Enrolls First Patient in Phase 3 Wet AMD Study
Ocular Therapeutix announced that the first patients have been enrolled in its Phase 3 SOL-R clinical trial. This study aims to assess the repeat dosing of AXPAXLI™ (axitinib intravitreal implant, also known as OTX-TKI) for treating wet age-related macular degeneration…
Eyenovia and SGN Nanopharma to Develop Dry Eye Treatment
Eyenovia and SGN Nanopharma have announced a new collaboration to develop a treatment for chronic dry eye disease. Eyenovia, known for its two FDA-approved products and a late-stage asset in pediatric progressive myopia, will work with SGN Nanopharma to develop…
Novaliq’s Vevizye® Receives Positive CHMP Opinion for DED
Novaliq announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion recommending the granting of a marketing authorization for Vevizye® in the European Union. This therapy is designed to treat moderate…
Elon Musk’s Blindsight Implant Faces Skepticism from Researchers
Elon Musk recently announced on X that Blindsight, a cortical implant to restore vision, would have low resolution at first “but may ultimately exceed normal human vision.” Skepticism from University of Washington Research New research from the University of Washington…
Dr. Allen C. Ho Appointed Chairman of Alcon Research Institute
Alcon announced that Allen C. Ho, MD, will join the Alcon Research Institute’s (ARI) Executive Committee as chairman in October. The executive committee has overseen ARI’s mission to expand the frontiers of vision sciences globally since its founding in 1981,…
Researchers Discover Potential Therapeutic Target for Dry AMD
Researchers from the National Institutes of Health (NIH) have made a significant breakthrough in understanding the dysfunction associated with waste removal in the retina, offering new insights into dry age-related macular degeneration (AMD). A recent report from NIH and Johns…